John J. Bauer - Concepedia

Author

John J. Bauer

Uniformed Services University of the Health Sciences

Also Known As

J Bauer, J J Bauer, J. Bauer, J. J. Bauer, J.J. BAUER, J.J. Bauer, JOHN J. BAUER, John Bauer, John J Bauer, John J. Bauer

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Uniformed Services University of the Health Sciences Armed Forces Institute of Pathology Walter Reed Army Institute of Research Georgetown University Georgetown University Medical Center

About

John J. Bauer is an author at Uniformed Services University of the Health Sciences specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	17	784
2	Engineering	5	5	217
3	Biomedical Engineering	2	2	72
4	Biostatistics	2	2	116
5	Health Sciences	1	1	29

John J. Bauer

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
LAPAROSCOPIC VERSUS OPEN PYELOPLASTY: ASSESSMENT OF OBJECTIVE AND SUBJECTIVE OUTCOME John J. Bauer, Jay T. Bishoff, Robert G. Moore, The Journal of Urology	1999	269
Elevated Levels of Apoptosis Regulator Proteins P53 and BCL-2 are Independent Prognostic Biomarkers in Surgically Treated Clinically Localized Prostate Cancer John J. Bauer, Isabell A. Sesterhenn, F. K. Mostofi, The Journal of Urology	1996	227
CD34 IMMUNOHISTOCHEMICAL ASSESSMENT OF ANGIOGENESIS AS A PROGNOSTIC MARKER FOR PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY Marie‐Claude Bettencourt, John J. Bauer, Isabella A. Sesterhenn, The Journal of Urology	1998	174
Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy. Marie‐Claude Bettencourt, John J. Bauer, Isabell A. Sesterhenn, PubMed	1996	150
Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer Judd W. Moul, Marie‐Claude Bettencourt, Isabell A. Sesterhenn, Surgery Prognostic BiomarkersUrologyProtein ExpressionGenitourinary CancerMedicine	1996	140
Ki-67 Expression is a Prognostic Marker of Prostate Cancer Recurrence after Radical Prostatectomy Marie‐Claude Bettencourt, John J. Bauer, Isabell A. Sesterhenn, The Journal of Urology Surgical OncologyPathologyTumor BiologyMonoclonal Antibody Ki-67Oncology	1996	133
PREDICTING RISK OF PROSTATE SPECIFIC ANTIGEN RECURRENCE AFTER RADICAL PROSTATECTOMY WITH THE CENTER FOR PROSTATE DISEASE RESEARCH AND CANCER OF THE PROSTATE STRATEGIC UROLOGIC RESEARCH ENDEAVOR DATABASES Judd W. Moul, Roger R. Connelly, Deborah P. Lubeck, The Journal of Urology	2001	128
Feasibility of Telementoring Between Baltimore (USA) and Rome (Italy): The First Five Cases Salvatore Micali, Gianni Virgili, E. Vannozzi, Journal of Endourology	2000	121
P53 AND BCL-2 IMMUNOHISTOCHEMISTRY IN PRETREATMENT PROSTATE NEEDLE BIOPSIES TO PREDICT RECURRENCE OF PROSTATE CANCER AFTER RADICAL PROSTATECTOMY G. Bennett Stackhouse, Isabell A. Sesterhenn, John J. Bauer, The Journal of Urology	1999	105
p53 nuclear protein expression is an independent prognostic marker in clinically localized prostate cancer patients undergoing radical prostatectomy. John J. Bauer, Isabell A. Sesterhenn, Kash Mostofi, PubMed UrologyPerineural InvasionDisease ProgressionGenitourinary CancerIndependent Prognostic Marker	1995	104

Page 1